Cargando…

Prognostic values of EDNRB in triple-negative breast cancer

Triple-negative breast cancer (TNBC) has a high degree of malignancy. The endothelin B receptor (EDNRB) serves an important role in the occurrence and development of cancer. The present study aimed to investigate the prognostic value of EDNRB in TNBC. A total of 99 cases of TNBC were collected from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shaoqing, Zhang, Jingyang, Zhu, Jiujun, Jiao, Dechuang, Liu, Zhenzhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471672/ https://www.ncbi.nlm.nih.gov/pubmed/32934717 http://dx.doi.org/10.3892/ol.2020.12012

Ejemplares similares

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis
por: Jiao, Dechuang, et al.
Publicado: (2021)

HN1L promotes migration and invasion of breast cancer by up‐regulating the expression of HMGB1
por: Jiao, Dechuang, et al.
Publicado: (2020)

Analysis of the expression profile of serum exosomal lncRNA in breast cancer patients
por: Zhao, Xin, et al.
Publicado: (2021)

Elevated Platelet Count Predicts Poor Prognosis in Breast Cancer Patients with Supraclavicular Lymph Node Metastasis
por: Liu, Shaoqing, et al.
Publicado: (2020)

ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022)

Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients
por: Zhu, Jiujun, et al.
Publicado: (2021)

Impact of Marital Status on Prognosis of Patients With Invasive Breast Cancer: A Population-Based Study Using SEER Database
por: Jiao, Dechuang, et al.
Publicado: (2022)

Association Between the HER2 Protein Expression Level and the Efficacy of Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
por: Yan, Hui, et al.
Publicado: (2020)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer
por: Chen, Cheng, et al.
Publicado: (2013)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen
por: Zhu, Jiujun, et al.
Publicado: (2022)

Characterization and prognostic value of LXR splice variants in triple-negative breast cancer
por: Lianto, Priscilia, et al.
Publicado: (2021)

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2016)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
por: Lin, Fei, et al.
Publicado: (2023)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
por: Tian, Tian, et al.
Publicado: (2016)

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
por: Ren, Xinyu, et al.
Publicado: (2023)

The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
por: Yin, Liu, et al.
Publicado: (2018)

Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma
por: Wei, Feiran, et al.
Publicado: (2020)

Exclusion of EDNRB and KIT as the basis for white spotting in Border Collies
por: Metallinos, Danika, et al.
Publicado: (2000)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer
por: Sharma, Priyanka, et al.
Publicado: (2014)

The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis
por: Lu, Yan-jun, et al.
Publicado: (2016)

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
por: Kuroda, Hajime, et al.
Publicado: (2021)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer
por: Wang, Yunxuan, et al.
Publicado: (2018)

Prognostic Value of the Evolution of HER2-Low Expression after Neoadjuvant Chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
por: Zhou, Yi-Fan, et al.
Publicado: (2021)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

Prognostic impact of PTK6 expression in triple negative breast cancer
por: Chen, Yuexia, et al.
Publicado: (2023)

Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
por: Cavallone, Luca, et al.
Publicado: (2020)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

QTL analysis of modifiers for pigmentary disorder in rats carrying Ednrb(sl) mutations
por: Huang, Jieping, et al.
Publicado: (2016)

Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
por: Bai, Yu-Ge, et al.
Publicado: (2020)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9gksjisjmlph3badn0kao4j09q